GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Revvity Inc (STU:PKN) » Definitions » Cyclically Adjusted Price-to-FCF

Revvity (STU:PKN) Cyclically Adjusted Price-to-FCF : 24.56 (As of May. 27, 2024)


View and export this data going back to 1983. Start your Free Trial

What is Revvity Cyclically Adjusted Price-to-FCF?

As of today (2024-05-27), Revvity's current share price is €103.40. Revvity's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €4.21. Revvity's Cyclically Adjusted Price-to-FCF for today is 24.56.

The historical rank and industry rank for Revvity's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

STU:PKN' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 19.25   Med: 35.78   Max: 64.63
Current: 24.89

During the past years, Revvity's highest Cyclically Adjusted Price-to-FCF was 64.63. The lowest was 19.25. And the median was 35.78.

STU:PKN's Cyclically Adjusted Price-to-FCF is ranked better than
61.9% of 63 companies
in the Medical Diagnostics & Research industry
Industry Median: 35.56 vs STU:PKN: 24.89

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Revvity's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €0.966. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €4.21 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Revvity Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Revvity's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revvity Cyclically Adjusted Price-to-FCF Chart

Revvity Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.73 53.77 52.65 31.74 24.64

Revvity Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.43 26.77 25.24 24.64 23.07

Competitive Comparison of Revvity's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Revvity's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revvity's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Revvity's Cyclically Adjusted Price-to-FCF falls into.



Revvity Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Revvity's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=103.40/4.21
=24.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revvity's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Revvity's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.966/131.7762*131.7762
=0.966

Current CPI (Mar. 2024) = 131.7762.

Revvity Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.297 100.560 0.389
201409 0.376 100.428 0.493
201412 0.655 99.070 0.871
201503 0.270 99.621 0.357
201506 0.453 100.684 0.593
201509 0.416 100.392 0.546
201512 0.937 99.792 1.237
201603 0.197 100.470 0.258
201606 0.713 101.688 0.924
201609 0.527 101.861 0.682
201612 1.217 101.863 1.574
201703 0.405 102.862 0.519
201706 0.343 103.349 0.437
201709 0.360 104.136 0.456
201712 0.844 104.011 1.069
201803 -0.271 105.290 -0.339
201806 0.430 106.317 0.533
201809 0.555 106.507 0.687
201812 0.997 105.998 1.239
201903 -0.240 107.251 -0.295
201906 0.240 108.070 0.293
201909 0.733 108.329 0.892
201912 1.548 108.420 1.881
202003 0.321 108.902 0.388
202006 0.968 108.767 1.173
202009 1.445 109.815 1.734
202012 3.476 109.897 4.168
202103 3.429 111.754 4.043
202106 1.975 114.631 2.270
202109 2.139 115.734 2.435
202112 2.155 117.630 2.414
202203 1.837 121.301 1.996
202206 0.583 125.017 0.615
202209 1.173 125.227 1.234
202212 0.845 125.222 0.889
202303 0.314 127.348 0.325
202306 -1.099 128.729 -1.125
202309 -0.421 129.860 -0.427
202312 1.283 129.419 1.306
202403 0.966 131.776 0.966

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Revvity  (STU:PKN) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Revvity Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Revvity's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Revvity (STU:PKN) Business Description

Traded in Other Exchanges
Address
940 Winter Street, Waltham, MA, USA, 02451
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Revvity (STU:PKN) Headlines